Sandeep K. Mallipattu (@skmallipattu) 's Twitter Profile
Sandeep K. Mallipattu

@skmallipattu

Professor of Medicine, Division of Nephrology @StonyBrookMed #Nephrology @sbudeptofmed #kidneyresearch @stonybrooku

ID: 878845088239104004

linkhttps://medicine.stonybrookmedicine.edu/medicine/nephrology/faculty/mallipattu_lab_overview calendar_today25-06-2017 05:19:31

446 Tweet

316 Followers

334 Following

NYCTrainKUHR (@nyctrainkuhr) 's Twitter Profile Photo

So proud of Sama DiMartino (NYCTrainKUHR Postdoc Fellow) Stony Brook Nephrology & Hypertension Division for being selected for Women in Nephrology Fellows School for Leadership Education! She’s already shining as Executive Secretary of U2C/TL1 Steering Committee for KUHR-TN Network. Congrats, Samaneh!

So proud of <a href="/SamaDimartino/">Sama DiMartino</a> (<a href="/NYCTrainKUHR/">NYCTrainKUHR</a> Postdoc Fellow) <a href="/SBNephrology/">Stony Brook Nephrology & Hypertension Division</a> for being selected for Women in Nephrology Fellows School for Leadership Education! She’s already shining as Executive Secretary of U2C/TL1 Steering Committee for <a href="/kuhr_trainees/">KUHR-TN</a> Network. Congrats, Samaneh!
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

The FY26 HHS Budget in Brief has been released. It outlines how the existing NIH institutes & centers will be combined into eight (with only NCI, NIA & NIAID retaining their original structure). There are 40% cuts proposed in NIH budget (including the NCI). 😢 Cancer Research 📉

The FY26 HHS Budget in Brief has been released. It outlines how the existing NIH institutes &amp; centers will be combined into eight (with only NCI, NIA &amp; NIAID retaining their original structure). 
There are 40% cuts proposed in NIH budget (including the NCI). 😢
Cancer Research 📉
Shipra Agrawal (@shipsagr) 's Twitter Profile Photo

Pleased to publish our work on podocyte RNA biology in glomerular disease in JASN. First report of splicing and polyadenylation in podocyte biology and glomerular disease. ASN Publications JASN_News International Society of Glomerular Disease International Podocyte Conference journals.lww.com/jasn/abstract/…

Eric Topol (@erictopol) 's Twitter Profile Photo

The first generative AI drug to get to a Phase 2 randomized clinical trial. The small molecule in pill form, rentosertib, showed signs of efficacy for idiopathic pulmonary fibrosis Nature Medicine Insilico Medicine nature.com/articles/s4159…

The first generative AI drug to get to a Phase 2 randomized clinical trial. The small molecule in pill form, rentosertib, showed signs of efficacy for idiopathic pulmonary fibrosis <a href="/NatureMedicine/">Nature Medicine</a> <a href="/InSilicoMeds/">Insilico Medicine</a> 
nature.com/articles/s4159…
NYCTrainKUHR (@nyctrainkuhr) 's Twitter Profile Photo

Huge congrats to Dr. Robert Bronstein Stony Brook University, our NYCTrainKUHR postdoc and expert in epigenetic regulation in Crescentic Glomerulopathies, named a 2025 KidneyCure grantee! So well-deserved—an inspiring future leader in the KUH field. So proud of you, Rob! Sandeep K. Mallipattu

Huge congrats to Dr. Robert Bronstein <a href="/stonybrooku/">Stony Brook University</a>, our <a href="/NYCTrainKUHR/">NYCTrainKUHR</a> postdoc and expert in epigenetic regulation in Crescentic Glomerulopathies, named a 2025 KidneyCure grantee! So well-deserved—an inspiring future leader in the KUH field. So proud of you, Rob! <a href="/SKMallipattu/">Sandeep K. Mallipattu</a>